Loading…
Antigenicity studies of prulifloxacin (NM441)
Antigenicity of prulifloxacin, a new antibacterial agent, and that of its active metabolite (NM394) were investigated using guinea pigs and mice in this study. In the study with guinea pigs, the animals were immunized with prulifloxacin by oral administration, the predetermined clinical route, and w...
Saved in:
Published in: | Journal of toxicological sciences 1996-06, Vol.21, p.231-239 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | Japanese |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | 239 |
container_issue | |
container_start_page | 231 |
container_title | Journal of toxicological sciences |
container_volume | 21 |
creator | TATEDA, C SAKAI, K YAMAKAWA, S NAKASUJI, T NAKAMURA, T SUMI, N SHINDO, Y |
description | Antigenicity of prulifloxacin, a new antibacterial agent, and that of its active metabolite (NM394) were investigated using guinea pigs and mice in this study. In the study with guinea pigs, the animals were immunized with prulifloxacin by oral administration, the predetermined clinical route, and with prulifloxacin alone or emulsified with Freund's complete adjuvant (FCA) by s.c. When active systemic anaphylaxis (ASA) test and passive cutaneous anaphylaxis (PCA) test of these animals were conducted by eliciting with NM394 alone or protein conjugate (NM394-GPSA) of NM394 and guinea pig serum albumin (GPSA), no ASA and PCA reactions were observed. When guinea pigs were immunized subcutaneously with protein conjugate (NM394-BSA) of NM394 and bovine serum albumin (BSA) together with FCA, ASA and PCA reactions were positive by eliciting with NM394-GPSA or NM394-BSA, but were negative by eliciting with NM394 alone. In the study with mice, the animals were immunized orally with prulifloxacin and intraperitoneally with prulifloxacin alone or suspended with aluminum hydroxide gel (alum). When rat PCA test of sera from these mice was conducted by eliciting with NM394 or NM394-GPSA, no positive PCA reaction was observed. When mice were immunized intraperiotneally with NM394-BSA together with alum, PCA reactions were positive by eliciting with NM394-GPSA or NM394-BSA, but were negative by eliciting with NM394 alone. These results show that prulifloxacin has no immunogenicity to guinea pigs and mice, and NM394 as its active form has no eliciting potential to anti-NM394-BSA antibody. |
doi_str_mv | 10.2131/jts.21.supplementi_231 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_78177819</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>78177819</sourcerecordid><originalsourceid>FETCH-LOGICAL-p150t-6334613da21fae0f84fd9c13ec36d760914bb27e7365776da24db4051b9b286b3</originalsourceid><addsrcrecordid>eNo9j81LxDAQxYMo67Lun6D0IKKHrplOmqTHZfELVr3ouSRpIpH0w6aF3f_egsXDMAPvN-_xCLkCuskA4f57iNOxiWPXBVvbZvBlhnBCliAlTbGQxSlZUpQyBczpOVnH6DWlCAIokwuykIIWwNmSpNvp-cs23vjhmMRhrLyNSeuSrh-Dd6E9KOOb5PbtlTG4uyBnToVo1_Nekc_Hh4_dc7p_f3rZbfdpBzkdUo7IOGClMnDKUieZqwoDaA3ySvApmmmdCSuQ50LwiWOVZjQHXehMco0rcvPn2_Xtz2jjUNY-GhuCamw7xlJIENMUE3g5g6OubVV2va9VfyznfpN-PesqGhVcrxrj4z-GIJExxF-78GF3</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78177819</pqid></control><display><type>article</type><title>Antigenicity studies of prulifloxacin (NM441)</title><source>Free Full-Text Journals in Chemistry</source><creator>TATEDA, C ; SAKAI, K ; YAMAKAWA, S ; NAKASUJI, T ; NAKAMURA, T ; SUMI, N ; SHINDO, Y</creator><creatorcontrib>TATEDA, C ; SAKAI, K ; YAMAKAWA, S ; NAKASUJI, T ; NAKAMURA, T ; SUMI, N ; SHINDO, Y</creatorcontrib><description>Antigenicity of prulifloxacin, a new antibacterial agent, and that of its active metabolite (NM394) were investigated using guinea pigs and mice in this study. In the study with guinea pigs, the animals were immunized with prulifloxacin by oral administration, the predetermined clinical route, and with prulifloxacin alone or emulsified with Freund's complete adjuvant (FCA) by s.c. When active systemic anaphylaxis (ASA) test and passive cutaneous anaphylaxis (PCA) test of these animals were conducted by eliciting with NM394 alone or protein conjugate (NM394-GPSA) of NM394 and guinea pig serum albumin (GPSA), no ASA and PCA reactions were observed. When guinea pigs were immunized subcutaneously with protein conjugate (NM394-BSA) of NM394 and bovine serum albumin (BSA) together with FCA, ASA and PCA reactions were positive by eliciting with NM394-GPSA or NM394-BSA, but were negative by eliciting with NM394 alone. In the study with mice, the animals were immunized orally with prulifloxacin and intraperitoneally with prulifloxacin alone or suspended with aluminum hydroxide gel (alum). When rat PCA test of sera from these mice was conducted by eliciting with NM394 or NM394-GPSA, no positive PCA reaction was observed. When mice were immunized intraperiotneally with NM394-BSA together with alum, PCA reactions were positive by eliciting with NM394-GPSA or NM394-BSA, but were negative by eliciting with NM394 alone. These results show that prulifloxacin has no immunogenicity to guinea pigs and mice, and NM394 as its active form has no eliciting potential to anti-NM394-BSA antibody.</description><identifier>ISSN: 0388-1350</identifier><identifier>EISSN: 1880-3989</identifier><identifier>DOI: 10.2131/jts.21.supplementi_231</identifier><identifier>PMID: 8709164</identifier><identifier>CODEN: JTSCDR</identifier><language>jpn</language><publisher>Tokyo: Japanese Society of Toxicology</publisher><subject>Anaphylaxis - immunology ; Animals ; Anti-Infective Agents - immunology ; Antigens - immunology ; Dioxolanes - immunology ; Female ; Fluoroquinolones ; Freund's Adjuvant - immunology ; Guinea Pigs ; Male ; Mice ; Mice, Inbred C57BL ; Passive Cutaneous Anaphylaxis - immunology ; Piperazines - immunology ; Quinolones - immunology ; Rats ; Serum Albumin - immunology ; Serum Albumin, Bovine - immunology</subject><ispartof>Journal of toxicological sciences, 1996-06, Vol.21, p.231-239</ispartof><rights>1996 INIST-CNRS</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=3183443$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8709164$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>TATEDA, C</creatorcontrib><creatorcontrib>SAKAI, K</creatorcontrib><creatorcontrib>YAMAKAWA, S</creatorcontrib><creatorcontrib>NAKASUJI, T</creatorcontrib><creatorcontrib>NAKAMURA, T</creatorcontrib><creatorcontrib>SUMI, N</creatorcontrib><creatorcontrib>SHINDO, Y</creatorcontrib><title>Antigenicity studies of prulifloxacin (NM441)</title><title>Journal of toxicological sciences</title><addtitle>J Toxicol Sci</addtitle><description>Antigenicity of prulifloxacin, a new antibacterial agent, and that of its active metabolite (NM394) were investigated using guinea pigs and mice in this study. In the study with guinea pigs, the animals were immunized with prulifloxacin by oral administration, the predetermined clinical route, and with prulifloxacin alone or emulsified with Freund's complete adjuvant (FCA) by s.c. When active systemic anaphylaxis (ASA) test and passive cutaneous anaphylaxis (PCA) test of these animals were conducted by eliciting with NM394 alone or protein conjugate (NM394-GPSA) of NM394 and guinea pig serum albumin (GPSA), no ASA and PCA reactions were observed. When guinea pigs were immunized subcutaneously with protein conjugate (NM394-BSA) of NM394 and bovine serum albumin (BSA) together with FCA, ASA and PCA reactions were positive by eliciting with NM394-GPSA or NM394-BSA, but were negative by eliciting with NM394 alone. In the study with mice, the animals were immunized orally with prulifloxacin and intraperitoneally with prulifloxacin alone or suspended with aluminum hydroxide gel (alum). When rat PCA test of sera from these mice was conducted by eliciting with NM394 or NM394-GPSA, no positive PCA reaction was observed. When mice were immunized intraperiotneally with NM394-BSA together with alum, PCA reactions were positive by eliciting with NM394-GPSA or NM394-BSA, but were negative by eliciting with NM394 alone. These results show that prulifloxacin has no immunogenicity to guinea pigs and mice, and NM394 as its active form has no eliciting potential to anti-NM394-BSA antibody.</description><subject>Anaphylaxis - immunology</subject><subject>Animals</subject><subject>Anti-Infective Agents - immunology</subject><subject>Antigens - immunology</subject><subject>Dioxolanes - immunology</subject><subject>Female</subject><subject>Fluoroquinolones</subject><subject>Freund's Adjuvant - immunology</subject><subject>Guinea Pigs</subject><subject>Male</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Passive Cutaneous Anaphylaxis - immunology</subject><subject>Piperazines - immunology</subject><subject>Quinolones - immunology</subject><subject>Rats</subject><subject>Serum Albumin - immunology</subject><subject>Serum Albumin, Bovine - immunology</subject><issn>0388-1350</issn><issn>1880-3989</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><recordid>eNo9j81LxDAQxYMo67Lun6D0IKKHrplOmqTHZfELVr3ouSRpIpH0w6aF3f_egsXDMAPvN-_xCLkCuskA4f57iNOxiWPXBVvbZvBlhnBCliAlTbGQxSlZUpQyBczpOVnH6DWlCAIokwuykIIWwNmSpNvp-cs23vjhmMRhrLyNSeuSrh-Dd6E9KOOb5PbtlTG4uyBnToVo1_Nekc_Hh4_dc7p_f3rZbfdpBzkdUo7IOGClMnDKUieZqwoDaA3ySvApmmmdCSuQ50LwiWOVZjQHXehMco0rcvPn2_Xtz2jjUNY-GhuCamw7xlJIENMUE3g5g6OubVV2va9VfyznfpN-PesqGhVcrxrj4z-GIJExxF-78GF3</recordid><startdate>199606</startdate><enddate>199606</enddate><creator>TATEDA, C</creator><creator>SAKAI, K</creator><creator>YAMAKAWA, S</creator><creator>NAKASUJI, T</creator><creator>NAKAMURA, T</creator><creator>SUMI, N</creator><creator>SHINDO, Y</creator><general>Japanese Society of Toxicology</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>199606</creationdate><title>Antigenicity studies of prulifloxacin (NM441)</title><author>TATEDA, C ; SAKAI, K ; YAMAKAWA, S ; NAKASUJI, T ; NAKAMURA, T ; SUMI, N ; SHINDO, Y</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p150t-6334613da21fae0f84fd9c13ec36d760914bb27e7365776da24db4051b9b286b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>jpn</language><creationdate>1996</creationdate><topic>Anaphylaxis - immunology</topic><topic>Animals</topic><topic>Anti-Infective Agents - immunology</topic><topic>Antigens - immunology</topic><topic>Dioxolanes - immunology</topic><topic>Female</topic><topic>Fluoroquinolones</topic><topic>Freund's Adjuvant - immunology</topic><topic>Guinea Pigs</topic><topic>Male</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Passive Cutaneous Anaphylaxis - immunology</topic><topic>Piperazines - immunology</topic><topic>Quinolones - immunology</topic><topic>Rats</topic><topic>Serum Albumin - immunology</topic><topic>Serum Albumin, Bovine - immunology</topic><toplevel>online_resources</toplevel><creatorcontrib>TATEDA, C</creatorcontrib><creatorcontrib>SAKAI, K</creatorcontrib><creatorcontrib>YAMAKAWA, S</creatorcontrib><creatorcontrib>NAKASUJI, T</creatorcontrib><creatorcontrib>NAKAMURA, T</creatorcontrib><creatorcontrib>SUMI, N</creatorcontrib><creatorcontrib>SHINDO, Y</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of toxicological sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>TATEDA, C</au><au>SAKAI, K</au><au>YAMAKAWA, S</au><au>NAKASUJI, T</au><au>NAKAMURA, T</au><au>SUMI, N</au><au>SHINDO, Y</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antigenicity studies of prulifloxacin (NM441)</atitle><jtitle>Journal of toxicological sciences</jtitle><addtitle>J Toxicol Sci</addtitle><date>1996-06</date><risdate>1996</risdate><volume>21</volume><spage>231</spage><epage>239</epage><pages>231-239</pages><issn>0388-1350</issn><eissn>1880-3989</eissn><coden>JTSCDR</coden><abstract>Antigenicity of prulifloxacin, a new antibacterial agent, and that of its active metabolite (NM394) were investigated using guinea pigs and mice in this study. In the study with guinea pigs, the animals were immunized with prulifloxacin by oral administration, the predetermined clinical route, and with prulifloxacin alone or emulsified with Freund's complete adjuvant (FCA) by s.c. When active systemic anaphylaxis (ASA) test and passive cutaneous anaphylaxis (PCA) test of these animals were conducted by eliciting with NM394 alone or protein conjugate (NM394-GPSA) of NM394 and guinea pig serum albumin (GPSA), no ASA and PCA reactions were observed. When guinea pigs were immunized subcutaneously with protein conjugate (NM394-BSA) of NM394 and bovine serum albumin (BSA) together with FCA, ASA and PCA reactions were positive by eliciting with NM394-GPSA or NM394-BSA, but were negative by eliciting with NM394 alone. In the study with mice, the animals were immunized orally with prulifloxacin and intraperitoneally with prulifloxacin alone or suspended with aluminum hydroxide gel (alum). When rat PCA test of sera from these mice was conducted by eliciting with NM394 or NM394-GPSA, no positive PCA reaction was observed. When mice were immunized intraperiotneally with NM394-BSA together with alum, PCA reactions were positive by eliciting with NM394-GPSA or NM394-BSA, but were negative by eliciting with NM394 alone. These results show that prulifloxacin has no immunogenicity to guinea pigs and mice, and NM394 as its active form has no eliciting potential to anti-NM394-BSA antibody.</abstract><cop>Tokyo</cop><pub>Japanese Society of Toxicology</pub><pmid>8709164</pmid><doi>10.2131/jts.21.supplementi_231</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0388-1350 |
ispartof | Journal of toxicological sciences, 1996-06, Vol.21, p.231-239 |
issn | 0388-1350 1880-3989 |
language | jpn |
recordid | cdi_proquest_miscellaneous_78177819 |
source | Free Full-Text Journals in Chemistry |
subjects | Anaphylaxis - immunology Animals Anti-Infective Agents - immunology Antigens - immunology Dioxolanes - immunology Female Fluoroquinolones Freund's Adjuvant - immunology Guinea Pigs Male Mice Mice, Inbred C57BL Passive Cutaneous Anaphylaxis - immunology Piperazines - immunology Quinolones - immunology Rats Serum Albumin - immunology Serum Albumin, Bovine - immunology |
title | Antigenicity studies of prulifloxacin (NM441) |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T04%3A49%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antigenicity%20studies%20of%20prulifloxacin%20(NM441)&rft.jtitle=Journal%20of%20toxicological%20sciences&rft.au=TATEDA,%20C&rft.date=1996-06&rft.volume=21&rft.spage=231&rft.epage=239&rft.pages=231-239&rft.issn=0388-1350&rft.eissn=1880-3989&rft.coden=JTSCDR&rft_id=info:doi/10.2131/jts.21.supplementi_231&rft_dat=%3Cproquest_pubme%3E78177819%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p150t-6334613da21fae0f84fd9c13ec36d760914bb27e7365776da24db4051b9b286b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=78177819&rft_id=info:pmid/8709164&rfr_iscdi=true |